Global Balloon Catheter Market

1 INTRODUCTION OF GLOBAL BALLOON CATHETER MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BALLOON CATHETER MARKET OUTLOOK
4.1 Overview

4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities

4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL BALLOON CATHETER MARKET, BY RAW MATERIAL
5.1 Polyurethane
5.2 Nylon
5.3 Others

6 GLOBAL BALLOON CATHETER MARKET, BY INDICATION
6.1 Coronary Artery Disease
6.2 Peripheral Vascular Disease

7 GLOBAL BALLOON CATHETER MARKET, BY END USER
7.1 Public Hospitals & Private Hospitals
7.2 Ambulatory Surgical Centres
7.3 Cardiac Catheterization Laboratories

8 GLOBAL BALLOON CATHETER MARKET, BY EXTRACTION METHOD
8.1 Distillation
8.2 Carbon Dioxide Extraction
8.3 Cold Press Extraction
8.4 Solvent Extraction
8.5 Other Extraction Methods

9 GLOBAL BALLOON CATHETER MARKET, BY GEOGRAPHY
9.1 Overview

9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico

9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe

9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific

9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina

9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL BALLOON CATHETER MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES

11.1 Boston Scientific Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 B. Braun Melsungen AG
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Medtronic
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Cordis Corporation
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Terumo Corporation
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Cook Medical Inc
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Micro Port Scientific Corporation
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Jotech GmbH
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Tokai Medical Products Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 QX Medical LLC
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Meril Life Pvt. Ltd.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Hexacath, Abbott Laboratories
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 Biosensors International Ltd
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

11.14 Cardionovum GmbH
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments

11.15 Biotronik Inc.
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments

12 Appendix
12.1 Related Reports